Aileron Therapeutics Inc (NASDAQ:ALRN)
| 1.36 BATS BZX Real-Time Price As of Mar 24 |  0.00 / 0.00%Today’s Change | 1.25 Today|||52-Week Range 15.00 | -42.83% Year-to-Date |
Latest ALRN News | Press Releases
| Aileron Therapeutics, Inc. (ALRN) Could Find a Support Soon, Here's Why You Should Buy the Stock Now Mar 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.36 |
| Today’s open | 1.35 |
| Day’s range | 1.35 - 1.36 |
| Volume | 415 |
| Average volume (3 months) | 47,259 |
| Market cap | $6.2M |
Data as of 3:17pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -2.17% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +2.06% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KTRAKintara Therapeutics... | 0.00 | 0.00% |
| KPRXKiora Pharmaceutical... | +0.08 | +2.39% |
| XBIOXenetic Biosciences ... | 0.00 | 0.00% |
| NBRVNabriva Therapeutics... | 0.00 | 0.00% |
Data as of 10:38am ET, 03/27/2023
Financials
| Next reporting date | April 3, 2023 |
| EPS forecast (this quarter) | -$1.27 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
